Sarah Schlesinger

Sarah Schlesinger

Director/Board Member at ARMATA PHARMACEUTICALS, INC.

Net worth: 3 M $ as of 2026-05-30

66 year
Commercial Services
Consumer Services
Health Technology

Profile

Dr. Sarah J.
Schlesinger
, MD, is an Independent Director at Armata Pharmaceuticals, Inc., a Lead Independent Director at Innoviva, Inc., an Associate Professor at The Rockefeller University, a Chairman at Rockefeller University Institutional Review Board, a Director-Education & Training at Rockefeller University Center For Clinical & Translational, a Member at American Association for the Advancement of Science, a Member at College of American Pathologists and a Member at United States & Canadian Academy of Pathology.
She is on the Board of Directors at Armata Pharmaceuticals, Inc., Innoviva, Inc., AIDS Vaccine Advocacy Coalition, Albert Einstein College of Medicine, Inc., eGenesis, Inc., Global Viral and The Hastings Center.
Dr. Schlesinger was previously employed as an Independent Director by The Medicines Co., an Independent Director by ARIAD Pharmaceuticals, Inc., a Member-Infectious & Parasitic Disease Pathology by Armed Forces Institute of Pathology, and a Chief Resident by NewYork-Presbyterian/Queens.
She also served on the board at Metabiota, Inc. She received her undergraduate degree from Wellesley College and a doctorate degree from Rush Medical College.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-05-03 140,492 ( 0.19% ) 3 M $ 2026-05-30
2026-04-16 0 ( -.--% ) - $ 2026-05-30

Sarah Schlesinger active positions

CompaniesPositionStart
INNOVIVA, INC. Director/Board Member 2018-02-11
ARMATA PHARMACEUTICALS, INC. Director/Board Member 2020-02-11
Director/Board Member -
Rockefeller University Institutional Review Board
Chairman 2016-12-31
Rockefeller University Center For Clinical & Translational
Corporate Officer/Principal -
Director/Board Member -
Corporate Officer/Principal -
Corporate Officer/Principal -
Corporate Officer/Principal -
░░░ ░░░░░░░░ ░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░ ░░░░░░░ ░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -

Former positions of Sarah Schlesinger

CompaniesPositionEnd
░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░ ░░░░░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ -
See the detail of Sarah Schlesinger's experience

Training of Sarah Schlesinger

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

67

1st degree connections

20

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies20

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Consumer Services

Consumer Services

Health Services

Commercial Services

Consumer Services

Government

Commercial Services

Consumer Services

Commercial Services

Consumer Services

Health Services

Health Technology

Rockefeller University Center For Clinical & Translational

Rockefeller University Institutional Review Board

  1. Stock Market
  2. Insiders
  3. Sarah Schlesinger